Modular Medical, Inc. Common Stock

Day range

$1.60 – $1.84

Open

$1.78

Prev close

$1.75

Volume

64.47K

Market cap

$16.62M

Shares out

9.5M

P/E

—

P/S

—

P/B

1.54

P/FCF

—

ROE

-260.4%

ROA

-228.7%

Debt/Equity

0.00

Div yield

0.00%

As of Oct 23, 2026

• Director departureSep 29, 2026

  On September 24, 2026, Carmen Volkart notified the chair of the NGC that she will not stand for re-election as a director upon the expiration of her current term, which expires at the Annual Meeting. Ms. Volkart's decision to not stand for re-election was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

• Shareholder meeting noticeSep 3, 2026

  On September 3, 2026, the board of directors of Modular Medical, Inc. set October 23, 2026 as the date of the Company's fiscal 2027 Annual Meeting of Shareholders (the "2027 Annual Meeting"). The 2027 Annual Meeting will be a virtual meeting. Shareholders of record at the close of business on September 10, 2026 will be entitled to notice of and to vote at the 2027 Annual Meeting.

• Executive compensation changeMay 20, 2026

  On May 14, 2026, the board of directors of Modular Medical, Inc. (the "Company") awarded 11,218 stock options to Paul DiPerna, the Company's Chairman, President, Chief Financial Officer and Treasurer, and 4,674 stock options to Kevin Schmid, the Company's Chief Operating Officer. The stock options have an exercise price of $3.46 per share of common stock and vest as follows: one-third of the shares subject to the option on May 14, 2027 and as to 1/24th of the remaining shares subject to the option on a monthly basis thereafter.

• Public offeringApr 21, 2026

  On April 19, 2026, Modular Medical, Inc. (the "Company") entered into a Placement Agency Agreement (the "Agreement") with Maxim Group LLC (the "Placement Agent"), relating to a registered direct offering (the "Offering") of 750,000 shares of the Company's common stock, par value $0.001 per share (the "Common Stock")... The gross proceeds to the Company from the Offering will be approximately $3.375 million, before deducting the Placement Agent fee and other offering expenses.

• Listing compliance regainedApr 16, 2026

  the Company received a notification letter on April 15, 2026 from the Listing Qualifications Department of the Nasdaq Stock Market notifying the Company that it had regained compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2)

Days to cover

3.7

Short interest

389.4K

Avg volume

106.27K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• AI-IoT Chipset Industry Insights and Forecast 2025-2035 - Expanding Applications Across Various Sectors Coupled With Strategic Startup Funding and Continuous Technological Advancements Drive Opportunities
  positiveGlobeNewswire Inc.· Apr 2, 2025
• Modular Medical (MODD) Pairing Technology Issued New U.S. Patent
  Zacks Investment Research· Feb 5, 2024
• Modular Medical, Inc. (MODD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
  Zacks Investment Research· Feb 2, 2024
• Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
  Benzinga· Oct 31, 2023
• Modular Medical And 2 Other Stocks Under $2 Insiders Are Buying
  Benzinga· Oct 19, 2023